Diagnosing metabolic syndrome in type 2 diabetic Turkish patients: Comparison of AHA/NHLBI and IDF definitions

Basol G.; Barutcuoglu B.; Cakir Y; Ozmen B.; Parildar Z.; Kose T; Ozmen D; Bayindir O.

Diagnosing metabolic syndrome in type 2 diabetic Turkish patients: Comparison of AHA/NHLBI and IDF definitions

Date

2011

Authors

Abstract

Objectives: The objective of this study was to determine the percentage of metabolic syndrome (MetS) in a Turkish population with type 2 diabetes mellitus (T2DM) according to the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) and International Diabetes Federation (IDF) definitions and to assess the agreement among these definitions. Background: It is essential to identify the prevalence of MetS in diabetic patients, as MetS is a stronger risk factor for cardiovascular disease in patients with T2DM than in non-diabetic subjects. Methods: 235 consecutive patients with T2DM were included in the study. The MetS was defined according to AHA/NHLBI and IDF definitions. Cohen's kappa was used as a measure of agreement between the two definitions. Logistic regression analysis was performed to calculate the odds ratios. Results: The percentage of MetS was 85.1 % by AHA/NHLBI and 87.2 % by IDF criteria. The agreement between AHA/NHLBI and IDF was fairly good (kappa=0.55). Females were more affected than males. When the frequencies of each individual feature of the MetS according the definitions were assessed, hypertension was the most common feature in males, whilst abdominal obesity was in females. Serum triglyceride and waist circumference had the highest predictive ability for MetS according to AHA/NHLBI and IDF definitions, respectively. Conclusion: The MetS is a common condition among diabetic patients. Since diabetic patients carry a cluster of cardiovascular risk factors, correct identification of the MetS among this population is of great importance, for an integrated approach to reduce the high costs and the associated disabilities.